Myeloid PGGT1B Deficiency Promotes Psoriasiform Dermatitis by Promoting the Secretion of Inflammatory Factors
Open Access
- 20 May 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4901
Abstract
Psoriasis pathogenesis involves dysregulated immune responses, yet the role of protein prenylation (particularly PGGT1B-mediated geranylgeranylation) in macrophage-driven inflammation remains poorly understood. This study aims to explore the role and molecular mechanism of protein geranylgeranyltransferase type I subunit beta (PGGT1B) in the development of psoriasis. Myeloid cell-specific PGGT1B gene knockout mice were generated, and a mouse psoriasis model was established with imiquimod to study the role and mechanism of PGGT1B gene downregulation-induced macrophage activation in the pathogenesis of psoriasis. Bone marrow-derived macrophages (BMDMs) from wild-type and PGGT1B knockout mice were cultured and stimulated with resiquimod (R848) to simulate the immune microenvironment of psoriasis. In addition, the differentially expressed genes induced by PGGT1B knockout were analyzed using RNA-seq, and bioinformatics analysis was carried out to study the possible biological process of PGGT1B regulation. Finally, PMA-THP-1 was co-cultured with HaCaT cells to study the effect of PGGT1B deletion in macrophages on the proliferation and differentiation of keratinocytes. Bone marrow PGGT1B deficiency aggravated the psoriasis-like lesions induced by imiquimod in mice. In BMDMs with PGGT1B deficiency, the NF-κB signaling pathway was over-activated by R848, and the expressions of proinflammatory cytokines IL-1β, IL-6, and TNF-α were significantly increased. Activation of cell division cycle 42 (CDC42) may mediate the activation of the NF-κB pathway in PGGT1B-deficient BMDMs. PGGT1B deletion can promote the proliferation and inhibit the differentiation of HaCaT cells. Reduced PGGT1B levels can increase the expression of CDC42, which further activates NLRP3 inflammation in macrophages through NF-κB signaling, further aggravating the inflammatory state of psoriasis. Psoriasis-like lesions induced by IMQ are aggravated when PGGT1B expression is reduced in mouse bone marrow cells. A possible mechanism for this is that PGGT1B-deficient macrophages migrate to the epidermis more easily during psoriasis, which leads to the activation of Cdc42, NF-κB signaling, and NLRP3 inflammatory corpuscles.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (3332021069, BK20210050, CIFMS-2021-I2M-1-001)
- Natural Science Foundation of Jiangsu Province (3332021069, BK20210050, CIFMS-2021-I2M-1-001)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (3332021069, BK20210050, CIFMS-2021-I2M-1-001)
This publication has 25 references indexed in Scilit:
- Low‐intensity pulsed ultrasound at ST36 improves the gastric motility by TNF‐α/IKKβ/NF‐κB signaling pathway in diabetic ratsJournal of Gastroenterology and Hepatology, 2023
- Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasisJournal of Allergy and Clinical Immunology, 2023
- Mouse Models of Psoriasis: A Comprehensive ReviewJournal of Investigative Dermatology, 2022
- The diagnostic significance of PGGT1B in psoriasisDermatologic Therapy, 2021
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in MiceGastroenterology, 2019
- Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactionsNature Communications, 2019
- Management of psoriasis as a systemic disease: what is the evidence?British Journal of Dermatology, 2019
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisClinical Reviews in Allergy & Immunology, 2018
- Cdc42 and Cellular Polarity: Emerging Roles at the GolgiTrends in Cell Biology, 2016